C-MER Eye Care Posts Strong Profit Growth

C-MER Eye Care Holdings Limited (HK:3309) has released an update.

C-MER Eye Care Holdings Limited reports a slight decrease in revenue by 2.9% for the first half of 2024 compared to the same period in 2023, but sees a notable increase in profit for the period by 28%. The company’s adjusted profit also surged by 54%, despite ceasing sales of COVID-19 related medical consumables in the second half of 2023. These results highlight a robust profit margin growth, reflecting the company’s financial resilience.

For further insights into HK:3309 stock, check out TipRanks’ Stock Analysis page.